• Protocols

• A091903

  OPEN TO ACCRUAL

  Phase II Trial of Adj Nivolumab +/- Cabozantinib in Patients with Resected Mucosal Melanoma
  
  

• S2015

  OPEN TO ACCRUAL

  PIII Randomized Trial Investigating 1CM v 2CM Wide Excision Margins for Primary Cutaneous Melanoma